Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Polymyositis”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Large-scale testing (Phase 3)Active Not RecruitingNCT05437263
What this trial is testing

Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Priovant Therapeutics, Inc. 241
Testing effectiveness (Phase 2)Study completedNCT03181893
What this trial is testing

A Study In Adults With Moderate To Severe Dermatomyositis

Who this might be right for
Dermatomyositis
Pfizer 75
Large-scale testing (Phase 3)Ended earlyNCT04999020
What this trial is testing

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Who this might be right for
Dermatomyositis
Alexion Pharmaceuticals, Inc. 38
Early research (Phase 1)UnknownNCT05986162
What this trial is testing

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Biotech Pharmaceutical Co., Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT06433999
What this trial is testing

A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis

Who this might be right for
DermatomyositisDermatomyositis, Adult Type
Priovant Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Looking for participantsNCT07111065
What this trial is testing

FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Who this might be right for
Dermatomyositis (DM)Juvenile Dermatomyositis (JDM)
National Institute of Environmental Health Sciences (NIEHS) 300
Large-scale testing (Phase 3)Looking for participantsNCT06455449
What this trial is testing

Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Who this might be right for
Polymyositis, Dermatomyositis
AstraZeneca 240
Not applicableLooking for participantsNCT07377058
What this trial is testing

RCT of Tocilizumab for Anti-MDA5+DM

Who this might be right for
Dermatomyositis
Peking Union Medical College Hospital 110
Early research (Phase 1)Looking for participantsNCT06916806
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06284954
What this trial is testing

Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Who this might be right for
DermatomyositisMyositis
argenx 3
Not applicableLooking for participantsNCT00017914
What this trial is testing

Adult and Juvenile Myositis

Who this might be right for
DermatomyositisPolymyositisInclusion Body Myositis
National Institute of Environmental Health Sciences (NIEHS) 1,200
Early research (Phase 1)Looking for participantsNCT06298019
What this trial is testing

Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis

Who this might be right for
Dermatomyositis
Stanford University 21
Early research (Phase 1)Study completedNCT00533091
What this trial is testing

Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Who this might be right for
DERMATOMYOSITIS OR POLYMYOSITIS
MedImmune LLC 51
Testing effectiveness (Phase 2)Looking for participantsNCT07089121
What this trial is testing

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Who this might be right for
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more
Cartesian Therapeutics 50
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240
Large-scale testing (Phase 3)Study completedNCT02971683
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
PolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more
Bristol-Myers Squibb 149
Load More Results